Skip to main content

R.J. Reynolds & Philips Morris Hit With $25M Tobacco Verdict

R.J. Reynolds & Philips Morris Hit With $25M Tobacco Verdict

R.J. Reynolds & Philips Morris Hit With $25M Tobacco Verdict

Introduction

On Wednesday, February 27, following a three-week trial, a Florida jury hit R.J. Reynolds Tobacco Co. and Philip Morris USA Inc. with $25 million in punitive damages for the victim's cigarette addiction and fatal lung cancer and awarded $12 million in compensatory damages to her widower. 

The jury ruled in favor of the plaintiff, awarding him an additional $5,500 for funeral expenses. Reynolds and Philip Morris both bore 45% responsibility for the woman's death, and the woman herself was held 10% responsible. The case is one among the thousands of cigarette smoking lawsuits originating from the Engle class action against tobacco companies.

In 2006, the Florida Supreme Court decertified the Engle class but later ruled that Engle progeny cases can be tried individually. The woman died in 1999, seven years after doctors detected her lung cancer and removed her right lung. Her family blamed R.J. Reynolds and Philips Morris for hiding cancer and respiratory disease risks caused due to smoking.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.